Veeva Systems Inc Class A (VEEV)

Currency in USD
278.57
-1.39(-0.50%)
Closed·
278.57+0.03(+0.01%)
·
VEEV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
273.92282.24
52 wk Range
148.05310.50
Key Statistics
Prev. Close
279.96
Open
278.5
Day's Range
273.92-282.24
52 wk Range
148.05-310.5
Volume
934.85K
Average Vol. (3m)
1.78M
1-Year Change
-4.9249%
Book Value / Share
45.75
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VEEV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
297.30
Upside
+6.72%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Veeva Systems Inc Class A News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

20 Buy
8 Hold
1 Sell
Ratings:
29 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 297.30
(+6.72% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
CFRA
Buy---UpgradeSep 15, 2026
Wells Fargo
Buy330.00+18.46%320.00MaintainSep 08, 2026
Citi
Hold273.00-2.00%190.00MaintainAug 27, 2026
TD Cowen
Buy283.00+1.59%235.00MaintainAug 27, 2026
UBS
Hold290.00+4.10%190.00MaintainAug 27, 2026

Veeva Systems Inc Class A SWOT Analysis


Growth Trajectory
Discover how Veeva projects 14% billings growth and EPS progression from $7.93 to $8.57, while navigating estimated $60 million revenue risk from competition
Analyst Outlook
Price targets range from Sector Weight to $305, with average targets around $305 from maintaining analysts, reflecting mixed views on competitive resilience
Competitive Dynamics
Salesforce's LifeScienceCloud has captured SMB customers and influenced large pharma evaluations, though Veeva retains 14 of top 20 pharmaceutical clients
Capital Allocation
Veeva announced a substantial $2 billion share buyback program over two years, signaling management's confidence in intrinsic value amid stock weakness
Read full SWOT analysis

Veeva Systems Inc Class A Earnings Call Summary for Q2/2027

  • Veeva Systems Q2 FY2026 revenue hit $928M, up 12% YoY, beating estimates of $905.4M; adjusted EPS of $2.35 topped forecast of $2.22.
  • Shares surged 9.43% after-hours to $268 following results; company raised FY2027 guidance citing strong execution and commercial momentum.
  • Commercial subscription revenue grew 13% YoY; company reported best-ever CRM quarter with 180+ Vault CRM customers live, winning Eli Lilly and Biogen.
  • CEO Gassner highlighted Falcon agentic labor product with five early adopters and first go-lives expected in FY2027; sees potential CRM win-backs from Salesforce.
  • Management noted R&D transition from legacy products to next-gen offerings like EDC and LIMS; IQVIA partnership improving significantly per executives.
Last Updated: 08/26/2026, 06:20 PM
Read Full Transcript
Veeva Systems A investor slides for Q2/2027
Veeva Q2'27 slides
Last Update: Aug 26, 2026
See full investor slides

Earnings

Latest Release
Aug 26, 2026
EPS / Forecast
2.35 / 2.22
Revenue / Forecast
927.96M / 905.41M
EPS Revisions
Last 90 days

VEEV Income Statement

Compare VEEV to Peers and Sector

Metrics to compare
VEEV
Peers
Sector
Relationship
P/E Ratio
44.3x32.7x−0.4x
PEG Ratio
1.750.320.00
Price / Book
6.1x2.0x2.6x
Price / LTM Sales
13.0x1.4x3.0x
Upside (Analyst Target)
6.2%41.4%57.5%
Fair Value Upside
Unlock46.0%7.8%Unlock

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
76.42M47.20%21.39B
Other Institutional Investors
71.47M44.14%20.01B
Public Companies & Retail Investors
14.02M8.66%3.93B
Total
161.91M100.00%45.33B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.7.94%12,862,5033,600,986
Vanguard Capital Management, LLC6.51%10,533,2862,948,899

People Also Watch

192.35
CRDO
-0.17%
292.21
COHR
+3.46%
973.49
LITE
+5.66%
140.83
VST
+2.04%
227.21
NVDA
-0.72%

FAQ

What Is the Veeva Systems A (VEEV) Stock Price Today?

The Veeva Systems A stock price today is 278.57 USD.

What Stock Exchange Does Veeva Systems A Trade On?

Veeva Systems A is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Veeva Systems A?

The stock symbol for Veeva Systems A is "VEEV."

What Is the Veeva Systems A Market Cap?

As of today, Veeva Systems A market cap is 45.05B USD.

What Is Veeva Systems A's Earnings Per Share (TTM)?

The Veeva Systems A EPS (TTM) is 6.10.

When Is the Next Veeva Systems A Earnings Date?

Veeva Systems A will release its next earnings report on Dec 09, 2026.

From a Technical Analysis Perspective, Is VEEV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Veeva Systems A Stock Split?

Veeva Systems A has split 0 times.

How Many Employees Does Veeva Systems A Have?

Veeva Systems A has 7928 employees.

What is the current trading status of Veeva Systems A (VEEV)?

As of Sep 29, 2026, Veeva Systems A (VEEV) is trading at a price of 278.57 USD, with a previous close of 279.96 USD. The stock has fluctuated within a day range of 273.92 USD to 282.24 USD, while its 52-week range spans from 148.05 USD to 310.50 USD.

What Is Veeva Systems A (VEEV) Price Target According to Analysts?

The average 12-month price target for Veeva Systems A is 297.30 USD, with a high estimate of 350 USD and a low estimate of 180 USD. 20 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +6.72% Upside potential.

What Is the VEEV Premarket Price?

VEEV's last pre-market stock price is 277.80 USD. The pre-market share volume is 7,250.00, and the stock has decreased by -2.16, or -0.77%.

What Is the VEEV After Hours Price?

VEEV's last after hours stock price is 278.57 USD, the stock has decreased by 0.03, or 0.01%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.